How do other banks ER teams survive?

I’ve been making a spreadsheet of all the banks on biotech IPOs, PIPEs, and follow-on deals, and it’s legit the same banks that take like 95% of the deals. So my question is: how the heck are these other banks biotech Analysts still around given they’re not bringing in fees? Biotech analysts aren’t exactly cheap so how are they around if their research doesn’t translate into deal fees through equity offerings, etc? 
 

Biotech banking syndicates usually involve the usual: Jefferies, Leerink, JPM, Piper, LifeSci, and Guggenheim. I see these banks consistently on deals, of course others exist but seem to be much less so. With the sheer volume of biotech equity deals just in the first 3 months of the year, are these guys absolutely crushing it? Is biotech a different world than other sectors? And seriously, should I go get a biotech masters and lateral to a biotech team from TMT??

 

who is LifeSci Capital and how are they on all these deals? Didn’t know about em and just looked it up. Good bank to join if they’re up and coming in biotech?
 

Also, Leerink is murdering this year for biotech holy hell. 

 

Accusantium consequatur qui enim ut. Est saepe fugiat alias quo doloremque sit illo. Molestiae cumque doloremque sunt ab quas atque voluptatem.

Occaecati sit id delectus repellendus. Esse voluptatem exercitationem soluta laudantium nihil occaecati repudiandae. Magnam debitis necessitatibus repudiandae nobis. Quam sed dolores sapiente odio deserunt. Impedit nobis reprehenderit temporibus sapiente quis nihil sint. Quos sapiente qui est autem temporibus.

Nam omnis ipsa fugiat ut. Quasi maxime sit nam est odio. Aut autem quod voluptas sint temporibus sunt sunt. Minus totam voluptatem doloremque et reprehenderit quia. Earum aut asperiores doloremque. Et dolore recusandae sed quis commodi distinctio velit. Dolores quia expedita error beatae itaque sed eaque.

Est quae sit id aut ipsa modi. Quae autem praesentium quo libero dicta. Delectus ut et odit quae. Ut adipisci quas expedita delectus.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
kanon's picture
kanon
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
bolo up's picture
bolo up
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”